Cree, B. A., Bennett, J. L., Kim, H. J., Weinshenker, B. G., Pittock, S. J., Wingerchuk, D., . . . Katz, E. (2021). Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD. Multiple sclerosis, 27(13), 2052. https://doi.org/10.1177/1352458521988926
Citace podle Chicago (17th ed.)Cree, Bruce Ac, et al. "Sensitivity Analysis of the Primary Endpoint from the N-MOmentum Study of Inebilizumab in NMOSD." Multiple Sclerosis 27, no. 13 (2021): 2052. https://doi.org/10.1177/1352458521988926.
Citace podle MLA (9th ed.)Cree, Bruce Ac, et al. "Sensitivity Analysis of the Primary Endpoint from the N-MOmentum Study of Inebilizumab in NMOSD." Multiple Sclerosis, vol. 27, no. 13, 2021, p. 2052, https://doi.org/10.1177/1352458521988926.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..